We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




European Market for Patient-Monitoring Devices

By HospiMedica staff writers
Posted on 20 Sep 2005
In spite of the crucial role of patient-monitoring devices in the intensive care units (ICUs) of hospitals, the market for these devices is facing problems in Europe as national governments come under increasing pressure to reduce the number of hospitals in their countries. More...
The market is rapidly reaching maturity, and future growth is becoming dependent upon the replacement of existing equipment, according to a new report from Frost & Sullivan (Palo Alto, CA, USA), a global consulting company.

Manufacturers of patient-monitoring devices need to maximize replacement opportunities by increasing R&D expenditures and developing advanced equipment that can replace existing devices. One trend in the market is the growing consolidation of companies in the form of mergers and acquisitions. Certain companies have a significant presence in one particular field, such as blood glucose monitoring, for example. Also, remote patient monitoring is due to expand because of the increasing number of aging baby boomers who might require intensive home care. More than 18% of the European population is now over 65.

"Disease management systems are the future of patient monitoring,” noted Aarati Ajay, a research analyst with Frost & Sullivan. "Systems with inherent abilities to monitor and interact with patients are expected to play a decisive role in the growth of the patient monitoring market.”

With the need to identify alternatives to hospital care, remote-patient monitoring could provide a timely solution. New technologic developments could also increase the market, as new wireless technology and remote monitoring are now doing.




Related Links:
Frost & Sullivan

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.